Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 19, Issue 3, 2005, Pages 294-299

  Mathew, Joseph P ^a   Grocott, Hilary P ^a   McCurdy II, James R ^a   Ti, Lian K ^a   Davis, R Duane ^a   Laskowitz, Daniel T ^a   Podgoreanu, Mihai V ^a   Swaminathan, Madhav ^a   Lynch, John ^a   Stafford Smith, Mark ^a   White, William D ^a   Newman, Mark F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

C reactive protein; Cardiopulmonary bypass; Cognition; Coronary artery bypass; Cytokine; Statin

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT REFERRAL; PREOPERATIVE CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL;

C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; COGNITION DISORDERS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RECEPTORS, INTERLEUKIN; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT FAILURE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20444420940     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.03.004     Document Type: Article

References (31)

1. C.J. Vaughan Prevention of stroke and dementia with statins Effects beyond lipid lowering Am J Cardiol 91 2003 23B 29B
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
3. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals A randomised placebo-controlled trial Lancet 360 2002 7 22
4. J.R. Downs, M. Clearfield, S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1998 1615 1622
5. J. Shepherd, G.J. Blauw, M.B. Murphy Pravastatin in elderly individuals at risk of vascular disease (PROSPER) A randomised controlled trial Lancet 360 2002 1623 1630
6. M. Kaste Statins in threatened stroke Stroke 34 2003 351 353
7. K. Yaffe, E. Barrett-Connor, F. Lin Serum lipoprotein levels, statin use, and cognitive function in older women Arch Neurol 59 2002 378 384
8. H. Jick, G.L. Zornberg, S.S. Jick Statins and the risk of dementia Lancet 356 2000 1627 1631
9. W. Balduini, V. De Angelis, E. Mazzoni Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury Stroke 32 2001 2185 2191
10. J.M. Murkin, S.P. Newman, D.A. Stump Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery Ann Thorac Surg 59 1995 1289 1295
11. S.J. George, A.J. Dhond, S.M. Alderson Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering Am J Cardiol 90 2002 1237 1239
12. P. Libby, M. Aikawa Mechanisms of plaque stabilization with statins Am J Cardiol 91 2003 4B 8B
13. C.J. Vaughan, N. Delanty Neuroprotective properties of statins in cerebral ischemia and stroke Stroke 30 1999 1969 1973
14. M. Endres, U. Laufs, Z. Huang Stroke protection by 3-hydroxy-3- methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase Proc Natl Acad Sci U S A 95 1998 8880 8885
15. L. Sironi, M. Cimino, U. Guerrini Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage Arterioscler Thromb Vasc Biol 23 2003 322 327
16. H.C. Bucher, L.E. Griffith, G.H. Guyatt Effect of HMGcoA reductase inhibitors on stroke A meta-analysis of randomized, controlled trials Ann Intern Med 128 1998 89 95
17. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels N Engl J Med 339 1998 1349 1357
18. J.F. Plehn, B.R. Davis, F.M. Sacks The Care Investigators Reduction of stroke incidence after myocardial infarction with pravastatin The Cholesterol and Recurrent Events (CARE) study Circulation 99 1999 216 223
19. M.F. Muldoon, S.D. Barger, C.M. Ryan Effects of lovastatin on cognitive function and psychological well-being Am J Med 108 2000 538 546
20. K. Rockwood, S. Kirkland, D.B. Hogan Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people Arch Neurol 59 2002 223 227
21. I. Hajjar, J. Schumpert, V. Hirth The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment J Gerontol A Biol Sci Med Sci 57 2002 M414 M418
22. N. Cutler, J. Sramek, A. Veroff Effects of treatment with simvastatin and pravastatin on cognitive function in patients with hypercholesterolaemia Br J Clin Pharmacol 39 1995 333 336
23. L.R. Wagstaff, M.W. Mitton, B.M. Arvik Statin-associated memory loss analysis of 60 case reports and review of the literature Pharmacotherapy 23 2003 871 880
24. R.P. Byington, B.R. Davis, J.F. Plehn Reduction of stroke events with pravastatin The Prospective Pravastatin Pooling (PPP) Project Circulation 103 2001 387 392
25. T.R. Pedersen, J. Kjekshus, K. Pyorala Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S) Am J Cardiol 81 1998 333 335
26. M. Thomas, J. Mann Increased thrombotic vascular events after change of statin Lancet 352 1998 1830 1831
27. C. Heeschen, C.W. Hamm, U. Laufs Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
28. K. Gertz, U. Laufs, U. Lindauer Withdrawal of statin treatment abrogates stroke protection in mice Stroke 34 2003 551 557
29. L. Puccetti, A.L. Pasqui, M. Pastorelli Platelet hyperactivity after statin treatment discontinuation Thromb Haemost 90 2003 476 482
30. J.K. Plenge, T.L. Hernandez, K.M. Weil Simvastatin lowers C-reactive protein within 14 days An effect independent of low-density lipoprotein cholesterol reduction Circulation 106 2002 1447 1452
31. S. Wassmann, A. Faul, B. Hennen Rapid effect of 3-hydroxy-3- methylglutaryl coenzyme a reductase inhibition on coronary endothelial function Circ Res 93 2003 e98 e3103